Cargando…
Current status of pathological image analysis technology in pharmaceutical companies: a questionnaire survey of the Japan Pharmaceutical Manufacturers Association
The Japan Pharmaceutical Manufacturers Association (JPMA) has instituted a task force (TF) for the “development of image analysis technology for histopathological changes” as part of the collaboration for realizing cutting-edge drug development since 2016. In recent years, there has been progress in...
Autores principales: | Yoshikawa, Tsuyoshi, Horai, Yasushi, Asaoka, Yoshiji, Sakurai, Takanobu, Kikuchi, Satomi, Yamaoka, Makiko, Tanaka, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Toxicologic Pathology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218240/ https://www.ncbi.nlm.nih.gov/pubmed/32425346 http://dx.doi.org/10.1293/tox.2019-0056 |
Ejemplares similares
-
Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021) -
Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011) -
The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017) -
Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014) -
Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)